Quinalizarin, a specific CK2 inhibitor, reduces cell viability and suppresses migration and accelerates apoptosis in different human lung cancer cell lines - Zhou, Y; Li, K; Zhang, S; Li, Q; Li, Z; Zhou, F; Meng, R (Indian J Cancer, 2015)